457 related articles for article (PubMed ID: 36273487)
1. Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands.
van der Loos MATC; Hannema SE; Klink DT; den Heijer M; Wiepjes CM
Lancet Child Adolesc Health; 2022 Dec; 6(12):869-875. PubMed ID: 36273487
[TBL] [Abstract][Full Text] [Related]
2. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
[TBL] [Abstract][Full Text] [Related]
3. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones.
van der Loos MATC; Vlot MC; Klink DT; Hannema SE; den Heijer M; Wiepjes CM
JAMA Pediatr; 2023 Dec; 177(12):1332-1341. PubMed ID: 37902760
[TBL] [Abstract][Full Text] [Related]
4. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
[TBL] [Abstract][Full Text] [Related]
5. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
[TBL] [Abstract][Full Text] [Related]
6. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria.
de Blok CJ; Wiepjes CM; van Velzen DM; Staphorsius AS; Nota NM; Gooren LJ; Kreukels BP; den Heijer M
Lancet Diabetes Endocrinol; 2021 Oct; 9(10):663-670. PubMed ID: 34481559
[TBL] [Abstract][Full Text] [Related]
7. Changes in Adrenal Androgens During Puberty Suppression and Gender-Affirming Hormone Treatment in Adolescents With Gender Dysphoria.
Schagen SEE; Lustenhouwer P; Cohen-Kettenis PT; Delemarre-van de Waal HA; Hannema SE
J Sex Med; 2018 Sep; 15(9):1357-1363. PubMed ID: 30224022
[TBL] [Abstract][Full Text] [Related]
8. Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents.
Nos AL; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E; Susi A; Roberts CM
JAMA Netw Open; 2022 Nov; 5(11):e2239758. PubMed ID: 36318207
[TBL] [Abstract][Full Text] [Related]
9. Continuation of Gender-affirming Hormones Among Transgender Adolescents and Adults.
Roberts CM; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3937-e3943. PubMed ID: 35452119
[TBL] [Abstract][Full Text] [Related]
10. Back to the Future: Is GnRHa Treatment in Transgender and Gender Diverse Adolescents Only an Extended Evaluation Phase?
Fisher AD; Ristori J; Romani A; Cassioli E; Mazzoli F; Cocchetti C; Pierdominici M; Marconi M; Ricca V; Maggi M; Vignozzi L; Castellini G
J Clin Endocrinol Metab; 2024 May; 109(6):1565-1579. PubMed ID: 38099569
[TBL] [Abstract][Full Text] [Related]
11. A European Network for the Investigation of Gender Incongruence in adolescents.
Boogers LS; Wiepjes CM; Staphorsius AS; Klink DT; Ciancia S; Romani A; Stolk THR; van den Boogaard E; Steensma TD; de Vries ALC; van Trotsenburg ASP; den Heijer M; Fisher AD; Cools M; Hannema SE
J Sex Med; 2024 Mar; 21(4):350-356. PubMed ID: 38427555
[TBL] [Abstract][Full Text] [Related]
12. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
[TBL] [Abstract][Full Text] [Related]
13. Biopsychosocial Assessments for Pubertal Suppression to Treat Adolescent Gender Dysphoria.
Turban JL; Thornton J; Ehrensaft D
J Am Acad Child Adolesc Psychiatry; 2024 Apr; ():. PubMed ID: 38582366
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial Characteristics of Transgender Youth Seeking Gender-Affirming Medical Treatment: Baseline Findings From the Trans Youth Care Study.
Chen D; Abrams M; Clark L; Ehrensaft D; Tishelman AC; Chan YM; Garofalo R; Olson-Kennedy J; Rosenthal SM; Hidalgo MA
J Adolesc Health; 2021 Jun; 68(6):1104-1111. PubMed ID: 32839079
[TBL] [Abstract][Full Text] [Related]
15. An appraisal of current service delivery and future models of care for young people with gender dysphoria.
McCallion S; Smith S; Kyle H; Shaikh MG; Wilkinson G; Kyriakou A
Eur J Pediatr; 2021 Sep; 180(9):2969-2976. PubMed ID: 33855617
[TBL] [Abstract][Full Text] [Related]
16. Growth in Transgender/Gender-Diverse Youth in the First Year of Treatment With Gonadotropin-Releasing Hormone Agonists.
Schulmeister C; Millington K; Kaufman M; Finlayson C; Kennedy JO; Garofalo R; Chan YM; Rosenthal SM
J Adolesc Health; 2022 Jan; 70(1):108-113. PubMed ID: 34315674
[TBL] [Abstract][Full Text] [Related]
17. Early puberty suppression and gender-affirming hormones do not alter final height in transgender adolescents.
Ciancia S; Klink D; Craen M; Cools M
Eur J Endocrinol; 2023 Sep; 189(3):396-401. PubMed ID: 37703317
[TBL] [Abstract][Full Text] [Related]
18. Impact of Hormone Treatment on Psychosocial Functioning in Gender-Diverse Young People.
Lavender R; Shaw S; Maninger JK; Butler G; Carruthers P; Carmichael P; Masic U
LGBT Health; 2023 Jul; 10(5):382-390. PubMed ID: 36989498
[No Abstract] [Full Text] [Related]
19. Impact of Early Medical Treatment for Transgender Youth: Protocol for the Longitudinal, Observational Trans Youth Care Study.
Olson-Kennedy J; Chan YM; Garofalo R; Spack N; Chen D; Clark L; Ehrensaft D; Hidalgo M; Tishelman A; Rosenthal S
JMIR Res Protoc; 2019 Jul; 8(7):e14434. PubMed ID: 31290407
[TBL] [Abstract][Full Text] [Related]
20. Association between pre-treatment IQ and educational achievement after gender-affirming treatment including puberty suppression in transgender adolescents.
Arnoldussen M; Hooijman EC; Kreukels BP; de Vries AL
Clin Child Psychol Psychiatry; 2022 Oct; 27(4):1069-1076. PubMed ID: 35638479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
